These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1679656)

  • 1. The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.
    Jack D
    Br J Clin Pharmacol; 1991 May; 31(5):501-14. PubMed ID: 1679656
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
    Nials AT; Sumner MJ; Johnson M; Coleman RA
    Br J Pharmacol; 1993 Feb; 108(2):507-15. PubMed ID: 8095419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the efficacy and affinity of the beta 2-adrenoceptor agonist salmeterol in guinea-pig trachea.
    Dougall IG; Harper D; Jackson DM; Leff P
    Br J Pharmacol; 1991 Dec; 104(4):1057-61. PubMed ID: 1687365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor.
    January B; Seibold A; Allal C; Whaley BS; Knoll BJ; Moore RH; Dickey BF; Barber R; Clark RB
    Br J Pharmacol; 1998 Feb; 123(4):701-11. PubMed ID: 9517390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta2-adrenoceptor agonists reduce the decline of rat diaphragm twitch force during severe hypoxia.
    van der Heijden HF; Heunks LM; Folgering H; van Herwaarden CL; Dekhuijzen PN
    Am J Physiol; 1999 Mar; 276(3):L474-80. PubMed ID: 10070112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
    Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
    Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid induction of REDD1 gene expression in macrophages in response to stress-related catecholamines.
    Yanagawa Y; Hiraide S; Matsumoto M; Togashi H
    Immunol Lett; 2014; 158(1-2):109-15. PubMed ID: 24374096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK; Cooper E; Vardey CJ; Peachell PT
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
    Yang Q; Battistini B; Pelletier S; Sirois P
    Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to a long-acting, selective beta 2-adrenoceptor stimulant.
    Brittain RT
    Lung; 1990; 168 Suppl():111-4. PubMed ID: 1974667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
    Carter AA; Hill SJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha).
    Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA
    Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of salmeterol.
    Johnson M; Butchers PR; Coleman RA; Nials AT; Strong P; Sumner MJ; Vardey CJ; Whelan CJ
    Life Sci; 1993; 52(26):2131-43. PubMed ID: 8099695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effect of salmeterol and salbutamol in normal subjects.
    Spring J; Clague J; Ind PW
    Br J Clin Pharmacol; 1992 Feb; 33(2):139-41. PubMed ID: 1348000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.
    Whelan CJ; Johnson M
    Br J Pharmacol; 1992 Apr; 105(4):831-8. PubMed ID: 1354536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization.
    Moore RH; Millman EE; Godines V; Hanania NA; Tran TM; Peng H; Dickey BF; Knoll BJ; Clark RB
    Am J Respir Cell Mol Biol; 2007 Feb; 36(2):254-61. PubMed ID: 16980556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
    Clark RB; Allal C; Friedman J; Johnson M; Barber R
    Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause of death in the SMART Trial.
    Williams C
    Chest; 2006 Sep; 130(3):929-30; author reply 930. PubMed ID: 16963700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.